| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6827031 | Schizophrenia Research | 2012 | 4 Pages |
Abstract
Critiques of the methods used in CATIE may have mitigated its potential impact on antipsychotic prescribing despite cost-effectiveness of perphenazine treatment.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Angela M. Koranek, Tawny L. Smith, Lisa M. Mican, Karen L. Rascati,